Literature DB >> 8719300

Morning plasma free cortisol: inability to distinguish patients with mild Cushing syndrome from patients with pseudo-Cushing states.

T C Friedman1, J A Yanovski.   

Abstract

Patients with Cushing syndrome have elevated 24 h urinary free cortisol excretion and loss of diurnal rhythm of plasma cortisol, however, morning total plasma cortisol concentrations are often similar to those of normal individuals. To test the hypothesis that an elevated morning plasma free cortisol could distinguish patients with Cushing syndrome from those without the disorder, we measured plasma free cortisol levels at 08:00 in 20 patients with surgically-confirmed mild Cushing syndrome, 19 patients with pseudo-Cushing states, and 9 normal volunteers. We then determined the sensitivity, specificity and diagnostic accuracy of plasma free cortisol for the diagnosis of hypercortisolism and for the diagnosis of Cushing syndrome. Plasma free cortisol was compared to 08:00 total plasma cortisol and to basal 24 hour urinary free cortisol. Morning plasma free cortisol was significantly elevated in patients with mild Cushing syndrome (58 +/- 6 nmol/L; mean +/- SE) compared to plasma free cortisol in patients with pseudo-Cushing states (36 +/- 6 nmol/L) (p < 0.005) and normal volunteers (22 +/- 4 nmol/L) (p < 0.0005). Total morning cortisol was significantly greater in patients with mild Cushing syndrome (470 +/- 28 nmol/L) than in normal volunteers (310 +/- 33 nmol/L, p < 0.05) but was not different from patients with pseudo-Cushing states (410 +/- 47 nmol/L, p = NS). Urinary free cortisol was also significantly greater in mild Cushing syndrome (540 +/- 50 nmol/d) than in patients with pseudo-Cushing states (430 +/- 41 nmol/d, p < 0.05) or normal volunteers (160 +/- 28 nmol/d, p < 0.0001). However, there was considerable overlap of plasma free cortisol, plasma total cortisol and urinary free cortisol between the three groups precluding these tests alone from being useful to distinguish patients with mild Cushing syndrome from patients with pseudo-Cushing states. To achieve 100% sensitivity for the diagnosis of Cushing syndrome, the specificity for plasma free cortisol, plasma total cortisol and urinary free cortisol was 0.11, 0.32 and 0.32, respectively. We conclude that plasma free cortisol is of limited value in the differential diagnosis of hypercortisolism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719300     DOI: 10.1007/BF03349791

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  MEASUREMENT OF CORTICOSTEROID-BINDING GLOBULIN IN MAN.

Authors:  R P DOE; R FERNANDEZ; U S SEAL
Journal:  J Clin Endocrinol Metab       Date:  1964-10       Impact factor: 5.958

2.  A radioimmunoassay for cortisol in plasma and urine.

Authors:  H J Ruder; R L Guy; M B Lipsett
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

3.  Single-antibody technique for radioimmunoassay of cortisol in unextracted serum or plasma.

Authors:  L B Foster; R T Dunn
Journal:  Clin Chem       Date:  1974-03       Impact factor: 8.327

Review 4.  Measuring the accuracy of diagnostic systems.

Authors:  J A Swets
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

5.  Cortisol binding to plasma proteins in man in health, stress and at death.

Authors:  D Murray
Journal:  J Endocrinol       Date:  1967-12       Impact factor: 4.286

6.  Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.

Authors:  P W Gold; D L Loriaux; A Roy; M A Kling; J R Calabrese; C H Kellner; L K Nieman; R M Post; D Pickar; W Gallucci
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

7.  A simple and rapid method to measure non-protein-bound fractions of cortisol, testosterone and oestradiol by equilibrium dialysis: comparison with centrifugal filtration.

Authors:  H K Kley; E Bartmann; H L Krüskemper
Journal:  Acta Endocrinol (Copenh)       Date:  1977-05

8.  The effect of glucocorticoids on corticosteroid binding globulin.

Authors:  J A Schlechte; D Hamilton
Journal:  Clin Endocrinol (Oxf)       Date:  1987-08       Impact factor: 3.478

9.  Effects of carbamazepine on pituitary-adrenal function in healthy volunteers.

Authors:  G I Perini; O Devinsky; P Hauser; W T Gallucci; W H Theodore; G P Chrousos; P W Gold; M A Kling
Journal:  J Clin Endocrinol Metab       Date:  1992-02       Impact factor: 5.958

10.  Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy.

Authors:  J P Luton; S Cerdas; L Billaud; G Thomas; B Guilhaume; X Bertagna; M H Laudat; A Louvel; Y Chapuis; P Blondeau
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

View more
  2 in total

1.  Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.

Authors:  R Görges; G Knappe; H Gerl; M Ventz; F Stahl
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

2.  LIMITATIONS OF BASAL CORTISOL IN THE DIAGNOSIS OF CUSHING SYNDROME.

Authors:  Amanda P T Barros; Elisa B Lamback; Maria Caroline A Coelho; Leonardo Vieira Neto
Journal:  AACE Clin Case Rep       Date:  2018-10-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.